You are here
Coverage of the latest news and updates from the field of stem cells and regenerative medicine.
Together the studies could lead to a way to help the heart regeneration itself following a heart attack, and offer new hope for the 17 million people who die from cardiovascular disease each year.
"The effect of these cells has continued for up to two years and has gotten stronger. There was also a major reduction in heart scarring," Bolli told the audience.
In response, Pluristem calls the Bloomberg article “factually inaccurate and misleading.”
In their study, published in the current issue of Cell Stem Cell, previously frozen stem cells restored production of sperm that successfully fertilized eggs to produce early embryos.
The finding, reported in the Oct. 18, 2012, issue of Cell Reports, could lead to new treatments that speed recovery of healthy blood levels for patients receiving chemotherapy or undergoing bone marrow and cord blood transplants.
Relapse rates, non-relapse mortality and acute graft-versus-host disease (GHVD) also appear unaffected.
October 2012 — Nearly $20 million has been allocated to advance promising therapies in diabetes and Beta-thalassemia from the lab into clinical trials. The grants, from the California Institute for Regenerative Medicine (CIRM), were made this week to biotech companies ViaCyte Inc.
Embryonic stem cells go through a process called self-renewal in which they undergo multiple cycles of division while not differentiating into any other type of cells. This process is dependent on three protein networks, but how these networks are integrated posed a mystery.